Click has secured financing in a round led by Sanofi Ventures as it develops digital medicines for conditions including depression, insomnia and chronic pain.

Sanofi Ventures, the corporate venturing arm of pharmaceutical firm Sanofi, has led a $17m financing round for US-based digital medicine developer Click Therapeutics.

Click creates prescriptive digital therapeutics that use cognitive and neurobehavioural mechanisms along with adaptive data science technology to help patients adapt behaviour.

The company’s software can be used in tandem with biomedical treatments, and Click’s lead product is an app that helps users stop smoking. It is developing treatments for depression, insomnia, acute coronary syndrome and chronic…